Baltimore, MD 的 卵巢癌 臨床試驗
22 項針對 卵巢癌 的研究正在 Baltimore（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
招募中2/3 期
- University of Maryland/Greenebaum Cancer Center, Baltimore
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- Johns Hopkins University, Baltimore
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
招募中3 期
- Research Site, Baltimore
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- University of Maryland, Baltimore /ID# 275308, Baltimore
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- United Theranostics, Glen Burnie · 距離 9 英里
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中2 期
- Greater Baltimore Medical Center, Baltimore
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
招募中1/2 期
- Research Site, Baltimore
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
招募中3 期
- Greater Baltimore Medical Center, Towson · 距離 8 英里
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- The John Hopkins Hospital, Baltimore
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
招募中3 期
- University of Maryland, Baltimore
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
招募中3 期
- Greater Baltimore Medical Center, Towson · 距離 8 英里
EXoPERT EMERALD Clinical Study
招募中觀察性研究歡迎健康志工
- John Hopkins University, Baltimore
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
招募中1 期
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
招募中2 期
- SCRI - Maryland Oncology Hematology, P.A., Annapolis · 距離 22 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 距離 8 英里
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
招募中2 期
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
招募中觀察性研究
- Johns Hopkins University School of Medicine, Baltimore
- Anne Arundel Health System, Annapolis · 距離 22 英里
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
招募中1/2 期
- Johns Hopkins, Baltimore
其他城市的 卵巢癌 試驗
- Houston, TX89 項研究
- New York City, NY69 項研究
- Boston, MA61 項研究
- Los Angeles, CA50 項研究
- Nashville, TN49 項研究
- Arlington, VA46 項研究
- Philadelphia, PA44 項研究
- Columbus, OH39 項研究
- St. Louis, MO38 項研究
- Chicago, IL36 項研究
- San Antonio, TX31 項研究
- Cleveland, OH30 項研究
Baltimore 的其他研究
- 非小細胞肺癌60 項研究
- 乳癌47 項研究
- 前列腺癌43 項研究
- 肺癌40 項研究
- 癌症（所有類型）37 項研究
- 胰臟癌31 項研究
- 大腸直腸癌31 項研究
- 轉移性癌症28 項研究
- 肥胖症26 項研究
- 膀胱癌24 項研究
- 心臟衰竭24 項研究
- 中風21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。